Yendou’s Mission to Cut 4 Years from Clinical Timelines by 2027

Yendou’s Mission to Cut 4 Years from Clinical Timelines by 2027

10 October 2023

In the past 50 years, there has been enormous innovation in the world of bits. Yet, not in the world of genome. Although innovation in medicine and biotechnology hasn't stalled, it hasn't progressed rapidly either.
‍


Consider clinical trials. Despite being pivotal in the war against diseases, now stretch over 12 years and cost an astronomical $1.2 billion each. This isn't just a financial burden; it's a delay in delivering lifesaving care.



But why should this matter to you? Because while we're advancing in technology, we're lagging in extending human life. The U.S. life expectancy has decreased by 2 years from 2018 to 2022. Non-aging related diseases claim 70% of global deaths. 



This isn't just a challenge; it's an opportunity—an opportunity for a leap in healthcare, for a breakthrough in how we develop therapeutics to fight diseases.



At Yendou, we say yes to the challenge and to the opportunity. 



Our mission is to supercharge the operational productivity of life sciences companies, enabling them to bring medical innovations to market faster and more efficiently.



Our technologies are designed to streamline clinical trial processes, reduce development costs, and shorten timeframes.

We believe that by enhancing the operational capabilities of life sciences firms, we can significantly contribute to advancing global health outcomes.

By 2030, Yendou will redefine industry benchmarks. We'll cut operational costs by 20% and reduce site activation time down to 4 months across all indications. 



We're not just aiming for progress; we're setting a new standard for it.

Yendou: Harnessing data and automation to streamline site selection and accelerate clinical breakthroughs.

The contents and works on these pages created by the site operators are subject to German copyright law. Duplication, processing, distribution and any form of commercialisation of such material beyond the scope of the copyright law shall require the prior written consent of its respective author or creator.

© 2024 and registered trademarks